Diagnostic Utility of Cardiac Troponin T Level in Patients with Cardiac Amyloidosis
Open Access
- 4 September 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 5 (1) , 27-35
Abstract
Aim The aim of this study was to evaluate the diagnostic utility of high-sensitivity cardiac troponin T (hs-cTnT) levels in discriminating cardiac amyloidosis from patients with cardiac hypertrophy caused by aetiologies other than cardiac amyloidosis. Methods and results Serum hs-cTnT levels were measured in 96 patients with cardiac amyloidosis (light chain: 23, wild-type transthyretin amyloidosis: 40, and mutated transthyretin amyloidosis: 33), and 91 patients with other causes of cardiac hypertrophy who were confirmed to have no cardiac amyloidosis by endomyocardial biopsy (control group). The diagnostic utility and cut-off value of hs-cTnT were evaluated by receiver operating characteristic analysis. The median hs-cTnT levels were higher in cardiac amyloidosis than the control group [0.048 (0.029–0.073) vs. 0.016 (0.010–0.031) ng/mL; P < 0.001]. High levels of hs-cTnT were suggestive of cardiac amyloidosis (cut-off value: 0.0312 ng/mL, sensitivity: 0.74, specificity: 0.76, area under the curve: 0.788; 95% confidence interval: 0.723–0.854, P < 0.001), compared with brain natriuretic peptide and E/e′ ratio. The hs-cTnT levels were also useful in differentiating each type of amyloidosis from the control group. Multivariate analysis identified log hs-cTnT as an independent diagnostic factor for cardiac amyloidosis (odds ratio: 2.22; 95% confidence interval: 1.30–3.80; P = 0.004). Conclusions High serum levels of hs-cTnT are highly suggestive of cardiac amyloidosis, allowing its differentiation from cardiac hypertrophy of other aetiologies. Further refined diagnostic approaches that include imaging modalities and histopathological examination are needed for these patients to avoid underdiagnosis of cardiac amyloidosis.Keywords
Funding Information
- Japan Society for the Promotion of Science (26860574)
- Japan Society for the Promotion of Science (26860574)
This publication has 32 references indexed in Scilit:
- Noncontrast T1 Mapping for the Diagnosis of Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2013
- Senile Systemic Amyloidosis: Clinical Features at Presentation and OutcomeJournal of the American Heart Association, 2013
- Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteinsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentEuropean Heart Journal, 2010
- Analytical Validation of a High-Sensitivity Cardiac Troponin T AssayClinical Chemistry, 2010
- Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2010
- Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy studyAnnals of Medicine, 2008
- Vascular abnormalities in primary amyloidosisEuropean Heart Journal, 2007
- Diagnosis and Management of the Cardiac AmyloidosesCirculation, 2005
- Cardiac Amyloidosis Presenting as Microvascular AnginaAngiology, 2001